Company Filing History:
Years Active: 2014
Title: Rubén Dario Sinisterra Millán: Innovator in Cardiovascular Therapeutics
Introduction
Rubén Dario Sinisterra Millán is a notable inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compositions aimed at treating cardiovascular diseases. His innovative work has led to the filing of a patent that addresses critical health issues.
Latest Patents
Rubén Dario Sinisterra Millán holds a patent for a "Process for the preparation of compositions of AT1 receptor antagonist and Angiotensin-(1-7)." This patent describes the preparation of compounds that include AT1 receptor antagonists and Angiotensin (1-7), such as Angiotensin-(1-7) losartanate and its analogues. The patent outlines the use of cyclodextrins and their derivatives for micro-encapsulation of these compounds, which can be utilized in controlled or sustained release devices for treating hypertension and various cardiovascular conditions.
Career Highlights
Rubén Dario Sinisterra Millán is affiliated with the Universidade Federal De Minas Gerais, where he continues to engage in research and development in the pharmaceutical field. His work focuses on innovative solutions for cardiovascular health, contributing to advancements in medical treatments.
Collaborations
Some of his notable coworkers include Cynthia Fernades Ferreira Santos and Robson Augusto Souza Dos Santos. Their collaborative efforts enhance the research output and innovation in their projects.
Conclusion
Rubén Dario Sinisterra Millán exemplifies the spirit of innovation in the pharmaceutical industry, particularly in the realm of cardiovascular therapeutics. His contributions through patents and research are paving the way for new treatment options for patients suffering from various cardiovascular diseases.